Bank of New York Mellon’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16M | Buy |
214,739
+3,737
| +2% | +$269K | ﹤0.01% | 1765 |
|
|
2026
Q1 | $15M | Sell |
211,002
-13,808
| -6% | -$944K | ﹤0.01% | 1692 |
|
|
2025
Q4 | $13.3M | Buy |
224,810
+19,513
| +10% | +$1.06M | ﹤0.01% | 1759 |
|
|
2025
Q3 | $11.3M | Sell |
205,297
-2,160
| -1% | -$112K | ﹤0.01% | 1863 |
|
|
2025
Q2 | $8.94M | Sell |
207,457
-6,922
| -3% | -$267K | ﹤0.01% | 1956 |
|
|
2025
Q1 | $8.49M | Sell |
214,379
-6,844
| -3% | -$303K | ﹤0.01% | 1934 |
|
|
2024
Q4 | $9.01M | Sell |
221,223
-37,766
| -15% | -$1.57M | ﹤0.01% | 1975 |
|
|
2024
Q3 | $10.1M | Sell |
258,989
-43,516
| -14% | -$1.73M | ﹤0.01% | 1920 |
|
|
2024
Q2 | $13.2M | Sell |
302,505
-22,808
| -7% | -$1.1M | ﹤0.01% | 1814 |
|
|
2024
Q1 | $15.5M | Sell |
325,313
-9,973
| -3% | -$448K | ﹤0.01% | 1724 |
|
|
2023
Q4 | $15.8M | Buy |
335,286
+4,245
| +1% | +$176K | ﹤0.01% | 1720 |
|
|
2023
Q3 | $15.8M | Sell |
331,041
-23,063
| -7% | -$1.26M | ﹤0.01% | 1661 |
|
|
2023
Q2 | $20.6M | Sell |
354,104
-34,923
| -9% | -$2.09M | ﹤0.01% | 1539 |
|
|
2023
Q1 | $27.8M | Sell |
389,027
-1,531
| -0.4% | -$122K | 0.01% | 1374 |
|
|
2022
Q4 | $27.5M | Sell |
390,558
-36,167
| -8% | -$2.55M | 0.01% | 1368 |
|
|
2022
Q3 | $25.9M | Sell |
426,725
-79,080
| -16% | -$5.31M | 0.01% | 1344 |
|
|
2022
Q2 | $31.9M | Sell |
505,805
-75,938
| -13% | -$4.95M | 0.01% | 1260 |
|
|
2022
Q1 | $37.3M | Sell |
581,743
-60,006
| -9% | -$4.01M | 0.01% | 1287 |
|
|
2021
Q4 | $46M | Buy |
641,749
+114,860
| +22% | +$8.74M | 0.01% | 1228 |
|
|
2021
Q3 | $37.6M | Sell |
526,889
-1,768
| -0.3% | -$139K | 0.01% | 1326 |
|
|
2021
Q2 | $43M | Buy |
528,657
+23,148
| +5% | +$1.86M | 0.01% | 1238 |
|
|
2021
Q1 | $38.2M | Buy |
505,509
+24,214
| +5% | +$1.76M | 0.01% | 1293 |
|
|
2020
Q4 | $36.4M | Sell |
481,295
-8,771
| -2% | -$571K | 0.01% | 1256 |
|
|
2020
Q3 | $24.2M | Sell |
490,066
-29,859
| -6% | -$1.69M | 0.01% | 1350 |
|
|
2020
Q2 | $27.3M | Buy |
519,925
+34,722
| +7% | +$1.65M | 0.01% | 1242 |
|
|
2020
Q1 | $17.1M | Sell |
485,203
-42,989
| -8% | -$2.51M | 0.01% | 1395 |
|
|
2019
Q4 | $46.2M | Sell |
528,192
-5,791
| -1% | -$506K | 0.01% | 1028 |
|
|
2019
Q3 | $45.3M | Sell |
533,983
-48,752
| -8% | -$4.34M | 0.01% | 1006 |
|
|
2019
Q2 | $61.3M | Buy |
582,735
+1,041
| +0.2% | +$105K | 0.02% | 842 |
|
|
2019
Q1 | $61.4M | Sell |
581,694
-51,736
| -8% | -$5.2M | 0.02% | 834 |
|
|
2018
Q4 | $53M | Sell |
633,430
-22,190
| -3% | -$2.01M | 0.02% | 838 |
|
|
2018
Q3 | $66.8M | Buy |
655,620
+14,402
| +2% | +$1.39M | 0.02% | 834 |
|
|
2018
Q2 | $51.8M | Sell |
641,218
-37,682
| -6% | -$2.99M | 0.01% | 979 |
|
|
2018
Q1 | $50M | Sell |
678,900
-8,617
| -1% | -$645K | 0.01% | 1002 |
|
|
2017
Q4 | $48.4M | Buy |
687,517
+6,622
| +1% | +$478K | 0.01% | 1037 |
|
|
2017
Q3 | $42.5M | Buy |
680,895
+28,345
| +4% | +$1.68M | 0.01% | 1085 |
|
|
2017
Q2 | $37.5M | Sell |
652,550
-5,156
| -0.8% | -$303K | 0.01% | 1149 |
|
|
2017
Q1 | $40M | Buy |
657,706
+11,628
| +2% | +$658K | 0.01% | 1093 |
|
|
2016
Q4 | $35.4M | Buy |
646,078
+45,936
| +8% | +$2.2M | 0.01% | 1168 |
|
|
2016
Q3 | $27.7M | Buy |
600,142
+6,201
| +1% | +$262K | 0.01% | 1252 |
|
|
2016
Q2 | $20.2M | Buy |
+593,941
| New | +$18.5M | 0.01% | 1400 |
|
Other funds holding NGVT
RHJA
LI
Bank of New York Mellon's NGVT Position: Q2 2026 in Review
Bank of New York Mellon increased its Ingevity (NGVT) stake by 1.8% in Q2 2026, buying an estimated $269K and bringing the position to 214,739 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #1765.
Bank of New York Mellon first reported a position in NGVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $66.8M in Q3 2018. 142 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Bank of New York Mellon held 214,739 shares of Ingevity worth $16M as of Q2 2026.
- Bank of New York Mellon bought 3,737 Ingevity shares in Q2 2026, an estimated $269K.
- Ingevity made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1765 holding.
- Bank of New York Mellon first reported a position in Ingevity in Q2 2016 and has held it in 41 quarters since.
- Bank of New York Mellon's Ingevity position peaked at $66.8M in Q3 2018.
- 142 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.